![Michael J. Marquard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Michael J.
Marquard was Chief Executive Officer and a Director of PDI, Inc. from May 2006 to June 20, 2008.
Prior to joining PDI, he had served as Vice President of Mylan Laboratories, Inc. and President of Mylan Bertek Pharmaceuticals, Inc. since July 2004.
Previously, Mr. Marquard served as Senior Vice President of U.S.
Sales for Wyeth since 1996 and served as a Member of the U.S.
Management Team and the Pharmaceutical Business Unit's Global Leadership Team.
From 1973 to 1995, he held a variety of positions at American Cyanamid Company, including Vice President and General Manager of Lederle Pharmaceuticals, Vice President and General Manager of Lederle Oncology and Vice President of Sales for Lederle Laboratories.
Mr. Marquard received an MBA from the University of Indianapolis and a BS from Youngstown State University.
Precedenti posizioni note di Michael J. Marquard
| Società | Posizione | Fine |
|---|---|---|
| INTERPACE BIOSCIENCES, INC. | Presidente | 20/06/2008 |
Mylan Laboratories, Inc.
 Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
8
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Interpace Biosciences, Inc.
 Interpace Biosciences, Inc. Medical SpecialtiesHealth Technology Provides commercialization services to biopharmaceutical companies | Health Technology |
